KLK3 and prostate carcinoma: Conventional tests for prostate cancer diagnoses using PSA are mainly performed in centralized laboratories using large-scale automated analyzers, and the associated medical costs increase due to various reasons, such as sample transport, increased waiting time, and simple management.